Recruiting

Observational StudyData2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention

Sponsor:

Chestnut Health Systems

Code:

NCT06852170

Conditions

Substance Abuse

Decision Making, Shared

Implementation Science

Decision Making

Organizations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Co-Design Sessions (CDS)

Data products

Study Details

Brief summary:

Oregon's decision makers (e.g., community service providers, public health, justice, advocacy groups, payers) are calling for comprehensive, current, and trusted data to inform how they allocate resources to improve substance use services and mitigate the growing opioid and methamphetamine epidemics in their state. Consistent with the HEAL Data2Action call for Innovation projects that drive action with data in real-world settings, this study will refine and test the impact of a novel implementation strategy to engage cross- sector decision makers and make data that they identify as relevant to their decisions available to them in easy- to-use products. The proposed study aims to not only address critical knowledge gaps regarding how and when data can inform impactful, transparent decision-making, but to provide decision makers with the data that they need to achieve community-wide substance use prevention and treatment goals, including the increased delivery of high-quality, evidence-informed, services and the prevention of overdoses.

Conditions

Substance Abuse

Decision Making, Shared

Implementation Science

Decision Making

Organizations

Study ID

NCT06852170

Start date

Feb 6, 2025

Status verified date

Mar, 2026

Completion date

Aug 31, 2028

Anticipated

Primary completion date

Jun 1, 2028

Anticipated

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

Sample 1: Local or Regional Decision Makers

At least 18 years old
Has decision-making authority within their professional role related to substance use service delivery, including leadership responsible for developing policy (e.g. executive directors) OR middle-managers (e.g., case managers, supervisor) and front-line workers responsible for service delivery decisions OR Responsible for developing local or state policy related to substance use/behavioral health and/or the criminal justice system OR Advises these decision makers (e.g., legislative staff, data analysts)

These individuals will be drawn from organizations with the following perspectives: behavioral health, public health, health payer, first responders, health advocacy.

Sample 2: State or Local Decision Makers

At least 18 years old
Has decision-making authority within their professional role related to substance use service delivery, including leadership responsible for developing policy (e.g. executive directors) OR middle-managers (e.g., case managers, supervisor) and front-line workers responsible for service delivery decisions OR Responsible for developing local or state policy related to substance use/behavioral health and/or the criminal justice system OR Advises these decision makers (e.g., legislative staff, data analysts)

Exclusion Criteria:

None.

Study Design

Enrollment

341 participants

Anticipated

Allocation

Randomized

Intervention Model

Sequential

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: CDS

This group will participate in 4 CDS to co-design and tailor data products with the study team. They will receive fully tailored Data Products at T3 or T4, depending on wedge assignment.

experimental: No CDS

This group will not participate in CDS. They will receive standardized data products at T3 or T4, depending on wedge assignment.

Interventions

Co-Design Sessions (CDS)

CDS uses principles and activities from Liberating Structures (LS) and Group Model Building (GMB). Each method uses semi-structured processes for engaging partners to collaborate with one another and address complex problems. Example activities and discussions include: identifying a shared vision for how data can inform decisions related to substance use service delivery and overdose prevention; identifying relevant data that should be disseminated; identifying decisions to be supported with data. Methods from human-centered design - an approach for developing products that are useful and easy to use - will be used to refine data products developed by the study team so that the data products are acceptable and useful to end users. Together, these three methods (Liberating Structures, group model building, human-centered design) will be used to engage partners to iteratively co-design products for disseminating data back to partners to inform their daily substance use service delivery.

Data products

Data products disseminate localized data from local, state, or regional-level data sources to local (i.e., county) decision makers to inform their daily decision-making. Data products in counties assigned to CDS will receive fully tailored data products, while no-CDS counties will receive standardized data products. A suite of data products will be made available to inform diverse decisions by a variety of end users. Data products will be identified and prioritized during CDS, but may include reports, policy briefs, journey maps, and technical assistance for data interpretation.

Primary outcome measure

Community Engagement Survey [ Time Frame: Measurement will occur at five timepoints: baseline, around 15 months post-baseline, around 18 months post-baseline, around 30 months post-baseline, around 42 months post-baseline ]

Central Contacts and Locations

Central contacts

Gracelyn Cruden, PhD, MA

541-461-5272 gcruden@chestnut.org

Jessica Harrison, MS

jlharrison@chestnut.org

Locations

Chestnut Health Systems

Recruiting

Eugene, Oregon, United States, 97401

Contacts

Gracelyn Cruden, PhD, MA

8435139928 gcruden@chestnut.org

Amanda J Broughton

ajbroughton@chestnut.org

Principal Investigator:

Gracelyn Cruden, PhD, MA

More Information

Sponsor

Chestnut Health Systems

Last update posted

Mar 16, 2026

Last verified

Mar, 2026

Keywords

Health Services Research
Sequential
Stepped Wedge
Substance Abuse
Implementation Science
Decision making
Substance-related disorders
Substance abuse treatment centers
Policy
Decision Making, Shared
Organizations
Focus Groups
Harm Reduction
Policy Making
Law Enforcement
User-Centered Design
Public Health
Opioid-Related Disorders
Naloxone
Methamphetamine
Health Disparate, Minority and Vulnerable Populations
Health Policy
Stakeholder engagement

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-08. This information was provided to ClinicalTrials.gov by Chestnut Health Systems on 2026-03-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.